Mesenchymal Stromal Cells Show Therapeutic Potential for Sepsis-Related Lung and Kidney Damage

A new peer-reviewed article highlights the potential of mesenchymal stromal cells (MSCs) as a treatment for acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) caused by sepsis. The research suggests MSCs could help reverse the underlying damage in these severe, life-threatening conditions.